FWIW, the insiders bought at the open market around this price range. Some are even underwater now so this is definitely a strong buy.
No. Deep in the money @ 2.50. When the implied volatility shoots up once we get close to the catalyst, I am going to sell some out of the money calls to derisk my bet.
No longer have significant R&D expenses, and Citrapure seem to be getting tractions so I think the earning will be decent, if not great.
You're obviously delusional.The funds don't even look at this. It will be a retail dominated stock unless the company do a RS and upgrade to the big board.
Yes. That's why the company hired Keith W. Schmidt as Chief Commercial Officer because they don't have any drug to sell. You seem smarter if you just shut your mouth.
FDA want to verify that the manufacturers (third-party) comply with CGMP standards. It might take several months to do that and if they find some issues, there will be further delay. Otherwise, the drug will be approved if no further issues raised.
Don't feed the troll. It's not like he is contributing anything anyway. He's just cluttering up the board. Just put the guy on ignore.